The trademark application ULTIRI was filed by Abbott Cardiovascular Systems Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on January 26, 2021, and it was registered by office on May 5, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).